No Data
No Data
Novo Nordisk Initiates Multi-Billion Share Buyback
Telehealth Firm Hims & Hers Health Rides High On Demand for Copycat Weight Loss Drugs Amid Supply Shortages
J&J, Roche Come Out on Top in S&P Ratings of Strongest Pharma Companies
Trending Stocks This Week as U.S. Equities Notch Their Best Week of 2024
The Trader: Medtronic Stock Has Hit Been by Anti-Obesity Concerns. Why It Should Rebound. -- Barron's
Doctors Struggle to Secure Medicare Coverage for Heart Patients on Novo Nordisk's Wegovy